DISGUSTING: CEO Got 671% Pay Raise While Hiking The Price Of Epi-Pens



The CEO of the company that drastically increased the price of EpiPens got huge pay increases over the years, with her salary reaching nearly $19 million annually.

According to filings reported by NBC News, Mylan Pharmaceuticals CEO Heather Bresch’s yearly compensation rose from $2,453,456 in 2007 to $18,931,068 last year.

The 671% raise for Bresch came after the company bought the rights to EpiPens, which are used to combat severe allergic reactions with an emergency injection of epinephrine.

In 2007, the Epi-Pen’s wholesale price was $56.64, but it has now grown 460% to a whopping $317.82. The company’s stock price more than tripled over that period.

Bresch is the daughter of Sen. Joe Manchin (D-WV) and some have called for congressional hearings after learning of her huge pay hikes amid the Epi-Pen price increases.

Bloomberg reported:

Congressional anger may be fueled by the company’s tactics in pushing legislation that helped boost the use of EpiPens.

Mylan spent about $4 million in 2012 and 2013 on lobbying for access to EpiPens generally and for legislation, including the 2013 School Access to Emergency Epinephrine Act, according to lobbying disclosure forms filed with the Office of the Clerk for the House of Representatives. Mylan also was the top corporate sponsor of a group called Food Allergy Research & Education that was the key lobbyist pushing for the bill encouraging schools to stock epinephrine auto-injectors, of which EpiPen is by far the leading product.

About Barry G. Morris

Leave a Reply

Your email address will not be published. Required fields are marked *